Xinran Chen1, Jian Wu1, Liangjie Lin2, Zhiliang Wei3, Lin Chen1, and Zhong Chen1
1Department of electronic science, Xiamen University, Xiamen, China, 2Clinical & Technical Support, Philips Healthcare, Beijing, China, 3Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States
Synopsis
Keywords: CEST & MT, Data Processing, Denoising
Chemical
exchange saturation transfer (CEST) is a powerful technique that enables
non-invasive detection of endogenous metabolites in living tissues. Since the
observed water signal is decreased due to the transfer of saturated spins, CEST
imaging inherently suffers from low SNR, hence degrading accuracy and
reproducibility. Inspired by the spatial-spectral correlation of CEST images, here
we propose a Subapace denoising method with Non-Local Low-Rank
constraint and Spectral-Smoothness regularization (SNLRSS) to diminish the
noise, which improves the accuracy of subsequent quantitative analyses
of
CEST images.
Introduction
Chemical exchange
saturation transfer (CEST) MRI is a versatile imaging technique that enables
indirect detection of diluted molecules by manipulating the water proton signal
through selective saturation of exchangeable protons1. Currently,
CEST MRI has been applied to detect various metabolites for the assessment of different
diseases, including ischemia, neurological disorders, and tumors2.
Despite the wide
potential applicability of CEST MRI, clinical exploitation is still
limited by low CEST contrast (commonly in the range of 1%-10%) and low
signal-to-noise (SNR) of acquired images, which challenge its reproducibility
and reliability. Several efforts have been made to improve the SNR in CEST MRI
by exploring the spatial-spectral correlation of CEST images, such as PCA,
NlmCED, and MLSVD. Although the abovementioned approaches work well generally, only
limited prior information was utilized. In this work, we propose a novel
subspace denoising method termed Subspace-based Non-Local Low-Rank and Spectral-Smoothness
constraint (SNLRSS) to fully exploit the spectral low-rankness, non-local
self-similarity and spectral-smoothness properties of CEST images. Methods
Theory of SNLRSS:
The flowchart of SNLRSS is shown in Figure 1. Forward variance-stabilizing
transformation (VST) is utilized to convert the signal-dependent Rician noise into
Gaussian-distributed noise in CEST images. The subspace decomposition is
applied to transform CEST images into low-dimensional orthogonal bases and subspace-based
images according to the spectral low-rank prior. Non-local
similarity prior is utilized to remove the noise of subspace-based images. The spectral-smoothness
regularization is implemented to further reduce oscillations in Z-spectrum. The
proposed model is solved by the alternating minimization (AM) scheme and alternating
direction method of multipliers (ADMM).
Simulation: Synthetic
CEST data with a matrix size of 128 × 128 were generated to evaluate the
performance of the denoising methods quantitatively. The Z-spectra were
generated using the Bloch-McConnell equation with three pools (bulk water, MT
pool, and creatine pool)3. The concentration of creatine pool in
different patterns was randomly selected from 10mM~100mM. A continuous-wave
saturation scheme (1 µT × 3 s) with 81 frequency offsets sampled from −6 to 6
ppm was employed in the simulation.
In vivo mouse experiment: The
in vivo ischemic stroke mouse experiment was performed on a horizontal bore 11.7
T (tesla) Bruker Biospec system (Bruker, Ettlingen, Germany) using a turbo spin-echo
sequence with a matrix size 64 × 64. A saturation scheme (2 µT × 1 s) with 49
frequency offsets from 1 to 5 ppm was employed.
To mimic a low SNR
situation, 1% Rician-distributed noise was artificially added to CEST images. The
polynomial and Lorentzian line-shape fitting (PLOF) method4 is
implemented to extract the CEST signal Rexch. The original CrCEST Rexch
maps were used as references.Results and Discussion
Figure 2
demonstrates the denoising results and difference maps for numerical simulation
with different denoising methods. All denoising methods yielded improved
outcomes (Figures 2I-2L) compared to the noisy results (Figure 2D). However, due
to the absence of spatial prior information, the performance of PCA was inferior
to other methods according to the SSIM (Figure 2M). NlmCED and MLSVD yielded
better performances in noise reduction compared to PCA. However, the edge
region of NlmCED outcome was unsatisfactory (Figure 2N) and MLSVD outcome
suffered from obvious blocking artifacts (Figure 2O). It can be concluded from
the difference maps and SSIM values that SNLRSS was advantageous in both spectral
fidelity and final quantification.
The results of in vivo
mouse experiment are shown in Figure 3. The ADC map was employed for
evaluating the stroke lesions (Figure 3A). Due to the decline of pH values, an obviously
reduced CrCEST contrast was observed in the ischemic regions, as demonstrated
in Figure 1C. Similar to simulation, all the methods improved the quality of
CEST maps (Figures 3E-3H), among which SNLRSS performed best in distinguishing ischemic
regions. From the Bland-Altman plots shown in Figures 3I-3L, SNLRSS yielded the
smallest deviation compared to the other denoising methods.
SSIM and PSNR were
used to objectively evaluate the performance of different denoising methods on
simulated CEST images with different additional noise levels. From Figure 4,
SNLRSS outperformed the other methods due to the utilization of more prior
information. Satisfactory result can be achieved by SNLRSS even under strong
noise level (e.g. 9%).Conclusion
In this study, a subspace denoising method with non-local low-rank constraint and spectral-smoothness regularization is proposed for CEST MRI. The performance of the proposed method was validated by the simulated and in vivo mouse experiments. By incorporating more prior information, the proposed method can achieve better performance in noise reduction compared to the other state-of-the-art methods, hence improving the sensitivity and accuracy of CEST MRI. The improved sensitivity without extending the total scan duration will facilitate the applications of CEST imaging in the mechanistic understanding on progressive developments of metabolic alterations in different diseases and in monitoring preclinical therapeutic trials. Acknowledgements
This work is
supported by Science and Technology Project of Fujian Province, grant number 2022J05013. The authors thank Dr. Yu Yang for valuable discussions.References
1. Ward
KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on
proton chemical exchange dependent saturation transfer (CEST). J Magn Reson
2000;143(1):79-87.
2. Zhou
J, et
al. Review and consensus recommendations
on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
Magn Reson Med 2022;88(2):546-574.
3. Zaiss M. CEST-sources.org.
https://www.cest-sources.org/doku. php. Accessed March 11, 2019.
4. Chen L, Schar M, Chan KWY, et al. In vivo
imaging of phosphocreatine with artificial neural networks. Nat Commun.
2020;11:1072